554 related articles for article (PubMed ID: 18598946)
1. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.
Ansieau S; Bastid J; Doreau A; Morel AP; Bouchet BP; Thomas C; Fauvet F; Puisieux I; Doglioni C; Piccinin S; Maestro R; Voeltzel T; Selmi A; Valsesia-Wittmann S; Caron de Fromentel C; Puisieux A
Cancer Cell; 2008 Jul; 14(1):79-89. PubMed ID: 18598946
[TBL] [Abstract][Full Text] [Related]
2. Deregulating EMT and senescence: double impact by a single twist.
Smit MA; Peeper DS
Cancer Cell; 2008 Jul; 14(1):5-7. PubMed ID: 18598938
[TBL] [Abstract][Full Text] [Related]
3. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
[TBL] [Abstract][Full Text] [Related]
4. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
[TBL] [Abstract][Full Text] [Related]
5. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells.
Li QQ; Xu JD; Wang WJ; Cao XX; Chen Q; Tang F; Chen ZQ; Liu XP; Xu ZD
Clin Cancer Res; 2009 Apr; 15(8):2657-65. PubMed ID: 19336515
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
[TBL] [Abstract][Full Text] [Related]
8. The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells.
Jacqueroud L; Bouard C; Richard G; Payen L; Devouassoux-Shisheboran M; Spicer DB; Caramel J; Collin G; Puisieux A; Tissier A; Ansieau S
Neoplasia; 2016 May; 18(5):317-327. PubMed ID: 27237323
[TBL] [Abstract][Full Text] [Related]
9. Twist1 is a key regulator of cancer-associated fibroblasts.
Lee KW; Yeo SY; Sung CO; Kim SH
Cancer Res; 2015 Jan; 75(1):73-85. PubMed ID: 25368021
[TBL] [Abstract][Full Text] [Related]
10. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
11. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
12. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
Liu Y; Mayo MW; Xiao A; Hall EH; Amin EB; Kadota K; Adusumilli PS; Jones DR
Mol Cell Biol; 2015 Jan; 35(1):303-17. PubMed ID: 25368381
[TBL] [Abstract][Full Text] [Related]
13. Breast tumor cell-specific knockout of
Xu Y; Lee DK; Feng Z; Xu Y; Bu W; Li Y; Liao L; Xu J
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11494-11499. PubMed ID: 29073077
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21, up-regulated by arsenite, directs the epithelial-mesenchymal transition and enhances the invasive potential of transformed human bronchial epithelial cells by targeting PDCD4.
Luo F; Ji J; Liu Y; Xu Y; Zheng G; Jing J; Wang B; Xu W; Shi L; Lu X; Liu Q
Toxicol Lett; 2015 Jan; 232(1):301-9. PubMed ID: 25445583
[TBL] [Abstract][Full Text] [Related]
15. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Lu K; Dong JL; Fan WJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8210-8219. PubMed ID: 30556860
[TBL] [Abstract][Full Text] [Related]
16. A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation.
Piccinin S; Tonin E; Sessa S; Demontis S; Rossi S; Pecciarini L; Zanatta L; Pivetta F; Grizzo A; Sonego M; Rosano C; Dei Tos AP; Doglioni C; Maestro R
Cancer Cell; 2012 Sep; 22(3):404-15. PubMed ID: 22975381
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
18. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
19. Modulation of oxidative stress by twist oncoproteins.
Floc'h N; Kolodziejski J; Akkari L; Simonin Y; Ansieau S; Puisieux A; Hibner U; Lassus P
PLoS One; 2013; 8(8):e72490. PubMed ID: 23967308
[TBL] [Abstract][Full Text] [Related]
20. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition.
Yang MH; Hsu DS; Wang HW; Wang HJ; Lan HY; Yang WH; Huang CH; Kao SY; Tzeng CH; Tai SK; Chang SY; Lee OK; Wu KJ
Nat Cell Biol; 2010 Oct; 12(10):982-92. PubMed ID: 20818389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
